Abstract

Biotechnology products have different registration requirements than of allopathic drugs. They need to be deeply evaluated in case of safety and efficacy.  Japan is the country which demands special requirements for registration of biotechnological products. Where as in Europe centralize procedure is mandatory for marketing of biotechnological products.

Keywords

Biotechnological products, Comparison

Cite This Article

Kanani, M. K., Pethani, T. M., Sheth, N., & Gandhi, S. N. (2014). Marketing Aspects of Biotechnological Products in Developed ICH Region - A Comparison. International Journal for Pharmaceutical Research Scholars (IJPRS), 3(2), 897-904.